Appendix 2—table 37. Antidiabetic Cohort (Region=New York State), Patient Characteristics Pre/Post Match.
| Region=NY by Antidiabetic Use: Unmatched | Region=NY by Antidiabetic Use: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | DIAB Non-users | DIAB Users | p-value | All | DIAB Non-users | DIAB Users | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 968,296 | 100.0% | 863,179 | 89.1% | 105,117 | 10.9% | 209,382 | 100.0% | 104,691 | 50.0% | 104,691 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 133,178 | 13.8% | 132,723 | 15.4% | 455 | 0.4% | <0.001 | 910 | 0.4% | 455 | 0.4% | 455 | 0.4% | 1.00 |
| 21-40 | 192,959 | 19.9% | 186,785 | 21.6% | 6,174 | 5.9% | 12,328 | 5.9% | 6,164 | 5.9% | 6,164 | 5.9% | ||
| 41-50 | 127,794 | 13.2% | 117,342 | 13.6% | 10,452 | 9.9% | 20,880 | 10.0% | 10,440 | 10.0% | 10,440 | 10.0% | ||
| 51-60 | 172,444 | 17.8% | 148,040 | 17.2% | 24,404 | 23.2% | 48,735 | 23.3% | 24,369 | 23.3% | 24,366 | 23.3% | ||
| 61-70 | 159,912 | 16.5% | 130,968 | 15.2% | 28,944 | 27.5% | 57,638 | 27.5% | 28,819 | 27.5% | 28,819 | 27.5% | ||
| 71-80 | 120,117 | 12.4% | 95,621 | 11.1% | 24,496 | 23.3% | 48,625 | 23.2% | 24,311 | 23.2% | 24,314 | 23.2% | ||
| ≥81 | 61,892 | 6.4% | 51,700 | 6.0% | 10,192 | 9.7% | 20,266 | 9.7% | 10,133 | 9.7% | 10,133 | 9.7% | ||
| Gender | ||||||||||||||
| Female | 573,610 | 59.2% | 512,889 | 59.4% | 60,721 | 57.8% | <0.001 | 120,937 | 57.8% | 60,467 | 57.8% | 60,470 | 57.8% | 0.99 |
| Male | 394,686 | 40.8% | 350,290 | 40.6% | 44,396 | 42.2% | 88,445 | 42.2% | 44,224 | 42.2% | 44,221 | 42.2% | ||
| Insurance | ||||||||||||||
| Commercial | 500,918 | 51.7% | 468,804 | 54.3% | 32,114 | 30.6% | <0.001 | 64,200 | 30.7% | 32,100 | 30.7% | 32,100 | 30.7% | 1.00 |
| Dual | 6,814 | 0.7% | 4,408 | 0.5% | 2,406 | 2.3% | 4,389 | 2.1% | 2,196 | 2.1% | 2,193 | 2.1% | ||
| Medicaid | 252,366 | 26.1% | 224,334 | 26.0% | 28,032 | 26.7% | 55,853 | 26.7% | 27,925 | 26.7% | 27,928 | 26.7% | ||
| Medicare | 208,198 | 21.5% | 165,633 | 19.2% | 42,565 | 40.5% | 84,940 | 40.6% | 42,470 | 40.6% | 42,470 | 40.6% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 521,282 | 53.8% | 484,071 | 56.1% | 37,211 | 35.4% | <0.001 | 74,215 | 35.4% | 37,106 | 35.4% | 37,109 | 35.4% | 0.99 |
| Yes | 447,014 | 46.2% | 379,108 | 43.9% | 67,906 | 64.6% | 135,167 | 64.6% | 67,585 | 64.6% | 67,582 | 64.6% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.65 | 1.39 | 0.56 | 1.30 | 1.34 | 1.84 | <0.001 | 1.32 | 1.79 | 1.32 | 1.79 | 1.32 | 1.79 | 0.98 |
CCI: Charlson Comorbidity Index; DIAB: antidiabetic; PCP: primary care physician; SD: standard deviation.